Rabies virus inactivated antigen, A

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates
Name
Rabies virus inactivated antigen, A
Accession Number
DB10283
Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Vaccines
Inactivated
Description

Rabies virus inactivated antigen, A is an inactivated virus vacine for the intramuscular injection. It is an active immunization against rabies that can be administered pre- or post-exposure to the rabies virus.

Synonyms
  • Rabies virus strain flury lep antigen (propiolactone inactivated)
  • Rabies virus vaccine flury-lep strain
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
RabAvert2.5 [iU]/1mLIntramuscularGlaxoSmithKline Biologicals SA2016-12-19Not applicableUs
RabAvertKit2.5 [iU]/1mLIntramuscularA-S Medication Solutions2016-12-19Not applicableUs
RabAvertKit2.5 [iU]/1mLIntramuscularA-S Medication Solutions2014-07-082020-03-31Us
RabAvertKit2.5 [iU]/1mLIntramuscularGSK Vaccines GmbH2014-07-082020-03-31Us
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Categories
UNII
C6547J35OD
CAS number
Not Available

Pharmacology

Indication
Not Available
Associated Conditions
Associated Therapies
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
2-MethoxyethanolThe therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with 2-Methoxyethanol.
9-(N-methyl-L-isoleucine)-cyclosporin AThe therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with 9-(N-methyl-L-isoleucine)-cyclosporin A.
AbataceptThe therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Abatacept.
AbetimusThe therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Abetimus.
ActeosideThe therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Acteoside.
AdalimumabThe therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Adalimumab.
AfelimomabThe therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Afelimomab.
AlclometasoneThe therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Alclometasone.
AldesleukinThe therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Aldesleukin.
AldosteroneThe therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Aldosterone.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347910469
ATC Codes
J06AA06 — Rabies serum

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedPreventionHealthy Volunteers / Rabies1
1CompletedPreventionMalaria caused by Plasmodium falciparum1
1CompletedPreventionPlasmodium Falciparum Malaria1
1CompletedPreventionPlasmodium Falciparum Malaria / Plasmodium Infections1
1CompletedPreventionPlasmodium Infections2
1CompletedPreventionRabies1
1Not Yet RecruitingTreatmentRabies1
1RecruitingPreventionRabies1
1RecruitingPreventionRabies / Rabies Immunisation1
1Unknown StatusPreventionPlasmodium Infections1
1, 2CompletedPreventionPlasmodium Infections1
1, 2RecruitingTreatmentMalaria caused by Plasmodium falciparum1
2Active Not RecruitingPreventionPlasmodium Infections1
2CompletedPreventionEncephalitis, Japanese B / Pre-Exposure Prophylaxis / Rabies1
2CompletedPreventionPlasmodium Falciparum Malaria1
2CompletedPreventionPlasmodium Infections3
2CompletedPreventionRabies6
2CompletedTreatmentHuman Immunodeficiency Virus (HIV) Infections1
2CompletedTreatmentRabies1
2RecruitingPreventionRabies1
2Unknown StatusPreventionRabies Pre-exposure Prophylaxis1
2, 3Active Not RecruitingNot AvailablePlasmodium Infections1
2, 3Active Not RecruitingTreatmentHealthy Volunteers1
2, 3Unknown StatusHealth Services ResearchRabies1
3CompletedPreventionAdverse Effect and Immunogenicity of Vaccine1
3CompletedPreventionEncephalitis, Japanese B / Meningococcal Disease / Meningococcal Meningitis / Rabies / Salmonella Typhi Infection / Yellow Fever1
3CompletedPreventionMalaria Vaccines / Plasmodium Infections1
3CompletedPreventionPlasmodium Infections2
3CompletedPreventionRabies2
3CompletedPreventionRabies Infection1
3CompletedPreventionRabies Post-exposure Prophylaxis1
3CompletedPreventionRabies Prevention1
3CompletedPreventionRabies / Rabies Virus1
3CompletedPreventionSafety, Immunogenicity1
3RecruitingPreventionRabies (Healthy Volunteers)2
4CompletedNot AvailableRabies1
4CompletedPreventionRabies3
4CompletedPreventionRabies Vaccine Allergy1
4CompletedTreatmentRabies1
4RecruitingBasic ScienceRabies Human1
4Unknown StatusHealth Services ResearchRabies1
4WithdrawnPreventionVirus Diseases1
Not AvailableCompletedPreventionEfficacy of the New CPRV1
Not AvailableCompletedPreventionRabies2
Not AvailableCompletedPreventionRabies Exposure / Rabies Prevention1
Not AvailableCompletedTreatmentRabies1
Not AvailableRecruitingTreatmentRabies2
Not AvailableUnknown StatusNot AvailableDog Bite1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
KitIntramuscular2.5 [iU]/1mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on November 30, 2015 14:24 / Updated on December 02, 2019 08:46